Bo Ahrén

71 – 80 of 398

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/af6f8d38-a95b-47b6-9ec5-5f69aa8d0e59?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
7
8
9
10
…
40
next »

2015
Mark The Islet and Metabolism Keep Time
Thorens, B. ; Accili, D. ; Ahrén, Bo ^LU ; Cerasi, E. ; Seino, S. and Boitard, C. (2015) In Diabetes, Obesity and Metabolism 17(Suppl 1). p.3-5
- Contribution to journal › Debate/Note/Editorial
Mark Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
Andersen, Birgitte ; Omar, Bilal ^LU ; Rakipovski, Günaj ; Raun, Kirsten and Ahrén, Bo ^LU (2015) In European Journal of Pharmacology 764. p.189-194
- Contribution to journal › Article
Mark Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Are there not some surrogate indexes lost in this story? Reply to Bastard JP, Rabasa-Lhoret R, Laville M and Disse E [letter]
Otten, Julia ; Ahrén, Bo ^LU and Olsson, Tommy (2015) In Diabetologia 58(2). p.416-417
- Contribution to journal › Letter
Mark DPP-4 inhibition contributes to the prevention of hypoglycaemia through a GIP-glucagon counterregulatory axis in mice.
Malmgren, Siri ^LU and Ahrén, Bo ^LU (2015) In Diabetologia 58(5). p.1091-1099
- Contribution to journal › Article
Mark Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Lind, Marcus ; Hirsch, Irl B ; Tuomilehto, Jaakko ; Dahlqvist, Sofia ; Ahrén, Bo ^LU ; Torffvit, Ole ^LU ; Attvall, Stig ; Ekelund, Magnus ^LU ; Filipsson, Karin ^LU and Tengmark, Bengt-Olov , et al. (2015) In BMJ: British Medical Journal 351. p.5364-5364
- Contribution to journal › Article
Mark Deciphering the hypoglycemic glucagon response: development of a graded hyperinsulinemic hypoglycemic clamp technique in female mice.
Malmgren, Siri ^LU and Ahrén, Bo ^LU (2015) In Endocrinology 156(10). p.3866-3871
- Contribution to journal › Article
Mark Creative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years?
Ahrén, Bo ^LU (2015) In Diabetologia 58(8). p.1740-1744
- Contribution to journal › Debate/Note/Editorial
Mark Incretin and islet hormone responses to meals of increasing size in healthy subjects.
Alsalim, Wathik ^LU ; Omar, Bilal ^LU ; Pacini, Giovanni ; Bizzotto, Roberto ; Mari, Andrea and Ahrén, Bo ^LU (2015) In Journal of Clinical Endocrinology and Metabolism 100(2). p.561-568
- Contribution to journal › Article
Mark Physiological aspects of the combination of insulin and GLP-1 in the regulation of blood glucose control.
Ahrén, Bo ^LU (2015) In Diabetes & Metabolism 41(6 Suppl 1). p.3-8
- Contribution to journal › Article
Mark Hepato-Incretin Function of GLP-1: Novel Concept and Target in Type 1 Diabetes.
Ahrén, Bo ^LU (2015) In Diabetes 64(3). p.715-717
- Contribution to journal › Debate/Note/Editorial

« previous
1
…
7
8
9
10
…
40
next »